Cangene Corporation

Cangene is a world leader in the development , manufacture, and commercialization of specialty hyperimmune plasma and biotechnology products. Cangene has built two decades of success with the life-antibody products, such as WinRho®SDF. We are the leader in the fight against infectious diseases such as smallpox, hepatitis B, and anthrax.

Contact Details: 155 innovation Drive Winnipeg Manitoba R3T 5Y3 Canada Tel: (204) 275-4178 Fax: (204) 269-7003 Email: sales@cangene.com WWW: www.cangene.com/

Loading...

Recent Publications by Cangene Corporation:
Pathogen safety of intravenous Rh immunoglobulin liquid and other immune globulin products: enhanced nanofiltration and manufacturing process overview. Plasma products for therapeutic use pose specific challenges in...	5th November, 2008	Product Development, Cangene Corporation, Winnipeg, Manitoba, Canada.	Am J Ther. 2008 Sep-Oct;15(5):435-43. DOI Direct Link
Comparative pharmacokinetics of liquid and lyophilized formulations of IV RhIG immune globulin. To compare the pharmacokinetics, safety, and tolerability of the liquid...	15th October, 2008	Cangene Corporation, Medical Affairs, 155 Innovation Drive, Winnipeg,	Biologicals. 2008 Jul;36(4):256-62. Epub 2008 Apr 10. DOI Direct Link
Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor. ABSTRACT Conjugates of recombinant human granulocyte-macrophage...	15th April, 2008	Cangene Corporation, Mississauga, ON, Canada M9W 6A9.	J Interferon Cytokine Res. 2008 Feb;28(2):101-12. DOI Direct Link
Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents. Burkholderia pseudomallei is a biothreat agent and an important natural...	4th April, 2008	Cangene Corporation, Mississauga, ON, Canada.	FEMS Immunol Med Microbiol. 2008 Jan;52(1):78-87. Epub 2007 Nov 11. DOI Direct Link
On the influence of vector design on antibody phage display. Phage display technology is an established technology particularly useful...	23rd March, 2007	Cangene Corporation, 3403 American Drive, Mississauga, Ontario L4V 1T4,	J Biotechnol. 2007 Jan 20;127(4):626-37. Epub 2006 Sep 22. DOI Direct Link
→View more Cangene Corporation research publications.

Press Releases on Cangene Corporation:
Reportlinker Adds World Market for Biosimilars and the Potential for US Follow-on Biologics, The Report	24th September, 2009	Reportlinker	-- Current market size and forecasts for biogenerics in Europe and Rest of World Markets -- Review of Marketed Biological Drugs with Expired Patents -- Review of
Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development	18th March, 2009	Alliance for Biosecurity	WASHINGTON, March 18 /PRNewswire-USNewswire/ -- David P. Wright, Co-Chair of the Alliance for Biosecurity and Chairman and CEO of PharmAthene, Inc., testified today before the House Labor, Health and

BioNews Results for Cangene Corporation:
Cangene acquires U.S. commercialization rights for HepaGam B from Apotex	Pharma Live:  Oct 23 2009 5:31AM Matching: cangene
Cangene acquires US commercialization rights for HepaGam B from Apotex	PharmaBiz:  Oct 22 2009 5:38AM Matching: cangene
Cangene acquires U.S. commercialization rights for HepaGam B from Apotex	Bionity.com:  Oct 22 2009 8:12AM Matching: cangene
Cangene Corporation announces financial results for the fiscal year ended July 31, 2009	News-Medical.Net:  Oct 22 2009 5:48AM Matching: cangene
Bay Street Stocks Finish Strong Thursday - Canadian Commentary	RTTNews.com:  Oct 22 2009 9:09PM Matching: cangene
Promote your company here: BioNewsCast - Press Release Distribution	→View more Cangene Corporation news.

Cangene Corporation Clinical Trials:
Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle

Cangene Corporation Patents:
US Patent No.	Title
6271344	Enhanced affinity hyaluronan binding peptides
5200327	Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces
5409818	Nucleic acid amplification process
5514590	Expression system comprising DNA encoding the signal peptide of protease B from Streptomyces griseus
5616485	Streptomyces proteases and improved streptomyces strains for expression of peptides and polypeptides
→View more Cangene Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 901 times since April 2007, the link to the organisation's website has been followed 94 times

Recent Search Terms used to find this page: cangene corporation | burkholderia cangene | cangene corporation | cangene corporation | cangene | cangene | cangene corporation | company profile of cangene | cangene manitoba | CANGENE WINNIPEG FREE PRESS | .

Search for more companies in Winnipeg

Search for more companies in Manitoba

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cangene Corporation